The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 08, 2018
Filed:
Aug. 04, 2017
Applicant:
Autotelic Llc, City of Industry, CA (US);
Inventor:
Vuong Trieu, Agoura Hills, CA (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61K 31/7125 (2006.01); A61K 31/407 (2006.01); A61K 31/337 (2006.01); A61K 31/282 (2006.01); A61K 31/519 (2006.01); A61K 31/495 (2006.01); A61K 31/513 (2006.01); A61K 9/00 (2006.01); A61K 31/7088 (2006.01); A61K 31/7068 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1136 (2013.01); A61K 9/0019 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/407 (2013.01); A61K 31/495 (2013.01); A61K 31/513 (2013.01); A61K 31/519 (2013.01); A61K 31/7068 (2013.01); A61K 31/7088 (2013.01); A61K 31/7125 (2013.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2320/31 (2013.01); C12N 2320/32 (2013.01); C12N 2320/35 (2013.01);
Abstract
Provided herein are composition for sensitizing tumors to anti-tumor therapies. The compositions include antisense oligonucleotides against TGFβ2, wherein the compositions sensitize tumors to anti-tumor therapies. Also provided herein are method for treating cancer using the compositions described herein.